Figure 4.

Tumor immunotherapy by peptide application to barrier-disrupted skin. Mice inoculated with B16 (n = 20) or 3LL (n = 20) were treated with TRP-2 or MUT1, respectively, on tape-stripped earlobes and then abdomen 2 days later. Percentage survival of the mice treated with peptide at tape-stripped skin (solid line), treated with tape-stripping only (dash–dot line), or treated with peptide at intact skin (dotted line) was monitored.